Setara Biosciences has raised $90 million in Series A financing to advance a pipeline of precision medicines targeting rare ...
Setara Biosciences, a San Diego biotech formed after Jazz Pharmaceuticals completed its acquisition of Actio Biosciences, has ...
Setara Biosciences Inc., a clinical-stage biotechnology company developing precision medicines for rare genetic diseases, has ...
Setara Biosciences has formed around a handful of assets from Actio Biosciences, which was acquired by Jazz Pharmaceuticals ...
Setara brings together an experienced team and a proven genetics-driven approach to design and development of small molecule ...
The drug programs left behind after Jazz Pharmaceuticals' $820 million acquisition of Actio Biosciences have found a new home ...
The fledgling startup has $90 million to develop a pipeline of drugs, led by a Charcot-Marie-Tooth disease medicine, that ...
Summary of Consolidated Financial Results for the Six Months Ended September 30, 2026 [IFRS] October 30, 2026 . Company Name: SUMITOMO PHARMA CO., LTD. Stock Exchange Listings: To ...
Frailty, but not HIV serostatus, is tied to more severe lower urinary tract symptoms in adults with and at risk for HIV, a ...
A concert you've been looking forward to. You arrive at the venue and head to the restroom, only to find a long line ...
Needing to go to the bathroom more often when it gets cold is a common bodily reaction. There are two reasons for this. 1.
A systematic review of thirteen qualitative studies identifies five themes in how women, caregivers and healthcare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results